83.62
1.14 (1.38%)
| Previous Close | 82.48 |
| Open | 83.07 |
| Volume | 501,789 |
| Avg. Volume (3M) | 809,400 |
| Market Cap | 4,593,542,656 |
| Price / Earnings (TTM) | 42.66 |
| Price / Earnings (Forward) | 19.53 |
| Price / Sales | 3.16 |
| Price / Book | 3.74 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Profit Margin | -17.42% |
| Operating Margin (TTM) | 15.54% |
| Diluted EPS (TTM) | -4.07 |
| Quarterly Revenue Growth (YOY) | 7.40% |
| Quarterly Earnings Growth (YOY) | 242.10% |
| Total Debt/Equity (MRQ) | 65.54% |
| Current Ratio (MRQ) | 1.58 |
| Operating Cash Flow (TTM) | 197.02 M |
| Levered Free Cash Flow (TTM) | 782.12 M |
| Return on Assets (TTM) | 4.55% |
| Return on Equity (TTM) | -19.70% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | LivaNova PLC | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -4.0 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | 4.0 |
| Average | -1.17 |
|
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 0.38% |
| % Held by Institutions | 102.95% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |